[Study of a drug combination with contraceptive, antibacterial, antimycotic and prophylactic action, for topical use in venereal diseases. 4. Effect of the combination of oxyquinoline sulfate, copper sulfate and lactic acid on Trichomonas vaginalis and on Candida albicans in vivo].
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002176:Candida albicans / Q000187:drug effects; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage; D003300:Copper / Q000008:administration & dosage* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines / Q000008:administration & dosage*; D007773:Lactates / Q000008:administration & dosage* / Q000627:therapeutic use; D015125:Oxyquinoline / Q000008:administration & dosage* / Q000627:therapeutic use; D012749:Sexually Transmitted Diseases / Q000188:drug therapy / Q000517:prevention & control; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D014246:Trichomonas vaginalis / Q000187:drug effects
D003271:Contraceptive Agents, Female; D004338:Drug Combinations; D006912:Hydroxyquinolines; D007773:Lactates; D015125:Oxyquinoline; D003300:Copper
Studio su un'associazione farmacoilogica per uso topico ad azione anticoncezionale, antibatterica, antimicotica e profilattica per le malattie veneree. Nota 4. Effetto dell'associazione ossichinolina solfato, solfato di rame ed acido lattico sul Trichomonas vaginalis e sulla Candida albicans in vivo.